Sonoma Biotherapeutics

We're excited to welcome Matteo Levisetti, M.D., as our Chief Medical Officer! Matteo brings 20+ years of immunology drug development experience across academia, pharma, and biotech.

Happy Memorial Day from @SonomaBio! Today, we remember the courageous men and women who have given their lives in service to our nation.

On this #ClinicalTrialsDay, we want to thank the investigators, participants, and loved ones who help change patients' lives across the world. Learn more about our Regulate-RA Phase I Trial of SBT-77-7101, in patients with rheumatoid arthritis here: bit.ly/4dkvNI4

As we recognize #MentalHealthAwarenessMonth, it’s important to acknowledge the often overlooked mental and emotional burden of chronic autoimmune disease. These lifelong conditions remain underserved by today’s therapies—driving SonomaBio’s mission to do more.

This year's World Health Day theme “Together for health. Stand with science,” highlights the power of scientific collaboration to protect the health of people, animals, plants, and our planet. At @sonomabio we believe everyone has a role to play in advancing global health.

See you in Miami! Our team is participating in the upcoming Leerink Global Healthcare Conference on Tuesday, March 10th. We look forward to engaging with the healthcare community while we’re there.

March is #AutoimmuneAwarenessMonth — recognizing the millions living with autoimmune diseases. We stand with patients, caregivers, and clinicians working to advance understanding and expand treatment options. Learn more about our approach: bit.ly/3MU9luF

On International Day of Women and Girls in Science, we celebrate the talented women at @SonomaBio whose expertise, curiosity, and leadership help drive our research forward. To all #WomenInSTEM, thank you for advancing science through expertise, dedication, and collaboration.

Today is #RheumAwarenessDay, recognizing the impact of a chronic autoimmune disease that affects the joints and can cause ongoing pain, swelling, and stiffness. At @SonomaBio, we are committed to advancing our clinical work in #RheumatoidArthritis.

Happy Holidays from all of us at @SonomaBio! We enjoyed closing out the year together at our annual Winter Celebration. We are grateful to our team for their hard work and dedication throughout the year. Wishing everyone a peaceful holiday season and happy new year!

Last week, we enjoyed gathering for our Nobel Night celebration as we sent-off our very own Fred Ramsdell and co-laureate Mary Brunkow to Stockholm to formally accept their Nobel Prize in Physiology and Medicine. It was a joyous night honoring this once-in-a-lifetime achievement!

During #CrohnsDisease and #UlcerativeColitis Awareness Week, we are reminded of the strength of those impacted by these diseases and the challenges they persevere through each day. You are not alone.

We are thrilled that Jeff Bluestone, Founder, Board Member, and Scientific Advisor to @SonomaBio will be joining the “State of the Art in Cell Therapy” panel at tomorrow’s Piper Sandler Healthcare Conference in New York City. Looking forward to an insightful discussion!

Happy Thanksgiving from @SonomaBio! We are so thankful for our dedicated employees and the scientific and clinical partners who share our mission to advance therapies for those struggling with autoimmune and inflammatory disease.

Happy #VeteransDay! Today, we pause to recognize the brave people who have served in the U.S. Armed Forces. Their courage, sacrifice, and dedication to protecting our freedoms deserve our deepest gratitude – not just today but every day.

Happy Halloween from all of us at @SonomaBio! We hope everyone enjoyed a spook-tacular celebration.

The @sonomabio team is honored to be sharing updates from our 7101 clinical trial for Hidradenitis Suppurativa at #SHSA2025. Learn more about our poster presentation here: bit.ly/49cntIL

We are excited to announce positive interim safety and efficacy data from the Phase 1 Regulate-RA study of SBT-77-7101 in refractory Rheumatoid Arthritis! The @sonomabio team looks forward to presenting these data today at #ACR2025 Read more here: bit.ly/4nmqKZ7

We are thrilled to be attending #ACR 2025, where our team will be sharing data from our 7101 Phase I clinical trial for Rheumatoid Arthritis. Learn more about our upcoming late-breaking oral and poster presentations here: bit.ly/3KNbaZ4

In honor of October being #GlobalDiversityAwarenessMonth, we want to highlight the various DEIB events taken place here at @sonomabio over the course of this year. We are so grateful for our team’s commitment to fostering a culture of inclusion and belonging in our workplace.